Jeffrey W. Sherman, Director: Xeris Biopharma Holdings XERS Buy · Filed 23/11/29

Trade details

Type: Insider buy
Amount: $10,098
Shares · price: 5,400 sh · $1.87 a share
Held after: 5,400 sh
Stock: Xeris Biopharma Holdings XERS
Person: Jeffrey W. ShermanDirector
Trade date: 23/11/27
Filed: 23/11/29
Days to filing: 2 days

3 insiders bought this week

Insiders buying this week: 3 insiders

Xeris Biopharma Holdings trades, last 26 weeks

What else happened in Xeris Biopharma Holdings around then

Filed or reported within 30 days of the trade day · 23/10/28~23/12/27

Jeffrey W. Sherman's recent trades

Jeffrey W. ShermanDirector
BuyLarimar Therapeutics
Buy
Larimar Therapeutics
LRMR
$25K
5,000 sh
$25K
Filed 03/02
Traded 02/27
Jeffrey W. ShermanDirector
SellXeris Biopharma Holdings
Sell
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/29
Traded 25/08/28
Jeffrey W. ShermanDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$334.5K
42,232 sh
$334.5K
Filed 25/08/28
Traded 25/08/28
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.8K
3,368 sh
$380.8K
Filed 23/01/12
Traded 23/01/10
Jeffrey W. ShermanEVP and Chief Medical Officer
SellHorizon Therapeutics Public
Sell
Horizon Therapeutics Public
HZNP
$380.9K
3,368 sh
$380.9K
Filed 23/01/12
Traded 23/01/11